The ever-increasing demand for more bandwidth to the home, office, and mobile devices is driving the deployment of 40G optical communications systems. Beginning in 2006, major carriers began deploying ...

Co-CEO Bob Duggan highlighted significant progress with ivonescimab, Summit Therapeutics' lead investigational asset, emphasizing its potential impact on unmet medical needs. Key milestones included ...

As the first tranche of quarterly results starts coming through for Big Pharma, questions are naturally arising about the new threats from COVID-19, but Swiss major Roche is also sticking to the old ...

Cytokinetics' share price surged on rumors of potential takeover interest from Novartis and AstraZeneca. The buyout of Myokardia shows how attractive an asset like aficamten can be, but the price tag ...